| Pressor | Start Dose | Typical Range | Receptors | Best For |
|---|---|---|---|---|
| Norepi | 0.01–0.05 | 0.05–1 | α1++ β1+ | Septic shock (first-line) |
| Vasopressin | 0.03 | Fixed 0.03 | V1 | Adjunct to norepi |
| Epinephrine | 0.01–0.05 | 0.02–0.3 | α1 β1 β2 | Refractory shock |
| Phenylephrine | 0.1–0.5 | 0.5–3 | α1 | Tachyarrhythmia, vasoplegia |
| Dopamine | 1–5 / 5–10 / 10–20 | — | D / β1 / α1 | Rarely used, bradycardia |
| Dobutamine | 2.5–5 | 5–20 | β1 β2 | Cardiogenic shock |
| Milrinone | — | 0.125–0.75 | PDE3 | RV failure, HF |
| Angiotensin II | 20 | 10–80 | AT1 | Refractory vasoplegia |
Comment 0
| No. | Subject | Author | Date | Views |
|---|---|---|---|---|
| 25 | Cardiogenic shock in ICU | Drhyo | 2025.11.16 | 18 |
| 24 | PE in ICU | Drhyo | 2025.11.16 | 16 |
| 23 | ICU Hemodynamic Values | Drhyo | 2025.11.16 | 15 |
| 22 | IVC | Drhyo | 2025.11.16 | 16 |
| 21 | AKI in ICU | Drhyo | 2025.11.16 | 19 |
| 20 | ICU steroid use | Drhyo | 2025.11.16 | 14 |
| 19 | ICU EMPIRIC ANTIBIOTICS | Drhyo | 2025.11.16 | 17 |
| 18 | ARDS Vent management | Drhyo | 2025.11.16 | 20 |
| 17 | NIV | Drhyo | 2025.11.16 | 13 |
| 16 | High Anion Gap Metabolic Acidosis MUDPILES | Drhyo | 2025.11.16 | 13 |
| 15 | Quick ICU ABG cause and treatment | Drhyo | 2025.11.16 | 13 |
| 14 | ABG Interpretation | Drhyo | 2025.11.16 | 15 |
| 13 | ABG example | Drhyo | 2025.11.16 | 15 |
| 12 | Paracentesis | Drhyo | 2025.11.16 | 17 |
| 11 | Thoracentesis | Drhyo | 2025.11.16 | 14 |
| 10 | Intubation | Drhyo | 2025.11.16 | 12 |
| 9 | ICU sedative, analgesics, paralytics table | Drhyo | 2025.11.16 | 17 |
| 8 | ICU Sedation Guide | Drhyo | 2025.11.16 | 18 |
| » | ICU pressors table | Drhyo | 2025.11.16 | 10 |
| 6 | ICU Pressors: Types, Doses, Receptors, Clinical Use | Drhyo | 2025.11.16 | 13 |